Isicwangciso B Isinyathelo esisinye esinyathelo sokukhulelwa ngokukhawuleza sisisicelo seziyobisi esivunywe yi-FDA ngoJulayi 13, 2009. Isicwangciso B Isinye Isinyathelo sinompilisi omnye womlomo (tablet ye-levonorgestrel, 1.5 mg). IsiCwangciso sokuqala B (kunye nesiqhelo sayo esifanayo, i- Next Choice ) sibandakanya ezimbini iipilisi zokukhusela eziphuculweyo kufuneka zithathwe iiyure eziyi-12 ngaphandle okanye ngexesha elinye. Ngokutsho kukaDenise Bradley, isithethi senkampani, "Cwangcisa iB One-Step ishintshe isiCwangciso seB."
Isicwangciso B Isinyathelo esisinye singasetyenziswe ngabasetyhini ukukhusela ukukhulelwa okungafunekiyo emva kwesondo esingakhuselekanga okanye ukuhluleka kokukhusela iipilisi enye enokuthi ithathwe ngokukhawuleza.
Amagqirha amaninzi, afana no-Ashlesha Patel, MD, MPH, uMlawuli weCandelo loNxibelelwano lwezeNtlalo kwi-John H. Stroger Jr. Hospital e-Chicago, khetha i-pill piling for their patients. Iifom zeyathelo elilodwa zivumela izigulane "ukuba zenze ngokukhawuleza ngelixa zinika izinga eliphezulu lokukhusela nokusebenza" kuchaza uDkt. Patel.
Phakathi ko-2012 kunye no-2014, i-FDA ivume ezi zilinganayo eziqhelekileyo kwiCwangciso B Elinye Isinyathelo: Ukhetho Olulandelayo , I- AfterPill , Indlela yam , kwaye uthathe isenzo .
Ingaba isebenza kanjani
Isicwangciso B Isinyathelo esinye Isisebenza kwiindlela ezininzi zokulawula ukuzalwa kwe-hormonal . Xa kuthethwa oko, kukho imbambano malunga neendlela ezichanekileyo ezicwangcisiweyo zeCwangciso B. Oku kungavumelani nxamnye nomba wokuba ungayicwangcanga okanye awuyi kuCwangcisa B Isinyathelo esinye Isithintelo sokwenza ukutshalwa kweqanda ekhulile.
Nangona i-FDA ifakiwe, kwi-label labeling, ukuba le ngenye yeendlela eziCwangcisa uB-One-Steps zisebenza, uluntu lwezonyango kwakunye neengxelo zophando olwangoku ukuba ukukhulelwa kwezibonelelo eziphuculweyo akukho mpe mbelelo ekufakweni.
Sisiphi isicwangciso B Isinyathelo esinye Isinyathelo
Ukukhulelwa kwexesha eliphuculweyo kudla ngokudidanisa ngokuphambene nepilisi yokukhupha isisu, i- RU486 (ekwabizwa ngokuba yi-M & M, iMifeprex, mifepristone okanye isisu sokukhupha isisu).
Ezi zonyango zimbini zijongene neenjongo ezimbini ezahlukeneyo kwaye zisebenza ngokuhlukileyo.
Cwangcisa i-One Step-step is not a pill. Kwakhona akusebenzi kakuhle xa kuthathwa emva kokuba umfazi sele ekhulelwe. ISicwangciso esitsha B asiyi kuphelisa ukukhulelwa okukhoyo. Ngokutsho kweTe Pharmaceuticals, umvelisi weCwangciso B-Inye-nyathelo, akukho ubungqina bokuba iSicwangciso B Isinye Isinyathelo silimaza umfazi okhulelweyo okanye umntwana okhulayo.
I-Teva Pharmaceuticals ikwacebisa ukuba iSicwangciso B esinye Isinyathelo akufanele sisetyenziswe njengesithuba sokusetyenziswa koqhawulo lwexesha.
Indlela Yokufumana
Kwimeko yamatyala iTimino v. Hamburg , ijaji yalela i-FDA ukuba ivumele iSicwangciso B esinye Isinyathelo sokuthengiswa phezu kwe-counter ngaphandle kwemingcele yeminyaka. Emva kwechungechunge lwezibheno, i-FDA yagqitywa ngokuvunywa kwayo kwiCwangciso B Elinye INyathelo elithengiswa ngaphaya kwe-counter to the people of any age . I-arhente iphinde yanikezwa nguTeva kuphela ukuthengisa iSicwangciso B Isinyathelo esisinye kwi-counter-counter. Kodwa, ngoFebhuwari 2014, i-FDA ifumene indlela yokuhlonela lo msebenzi wodwa xa ivumela ukuba iipilisi enye ifanasi ifumaneke kunye nokufikelela kwangaphambili kwe-counter.
Usenokufuna isidlo seSicwangciso B esinye Isinyathelo ukwenzela ukuba i-inshurensi yakho igubungele, ngoko unokufuna ukukhangela oko iimfuno zomgaqo-nkqubo wakho we-inshorensi ngaphambi kokuba uzifumene kwindawo yokufuna ukukhulelwa kwangxamisekileyo.
Isicwangciso B Isinyathelo esinye Isisetyenziselwa ukuba sigcinwe emva kwe-counter counter. Kufuneka kufumaneke kwisicwangciso sekhaya lesitoreji sakho / isigaba kunye neCandelo elilandelayo lokukhetha kunye neNdlela yam. Njengangoku, i-FDA isadinga ukuba i-Next Choice, ifom ye-2 yefomathi ye-Old Plan B egcinwe ngasemva kwe-counter-counter counter kwaye ifumaneka ngaphandle kwemvume kulabo abaneminyaka eli-17 nangaphezulu. Ngoko oku kuthetha ukuba imigaqo emitsha ye-FDA iyasebenza kuphela kwi-levonorgestrel-based based pililtive one-pilill.
Ixesha lokuLisebenzisa
Ukunciphisa umngcipheko wokukhulelwa okungenakulungiswa, iSicwangciso B Isinye Isinyathelo kufuneka sithathwe ngokukhawuleza kwangoko kwiiyure ezingama-72 (iintsuku ezi-3) zesini esingakhuselekanga okanye ukuhluleka kokukhulelwa .
Ngokukhawuleza iSicwangciso B esinye Isinyathelo sithathwa, siya kusebenza ngakumbi. Cwangciso B Isinye Isinyathelo sinokusetyenziswa nanini na ixesha ngexesha lokuhamba kwimizuzu. Ukuba uhlanza zingama-2 iiyure zokuthatha i pilisi, kufuneka udibanise noogqirha wakho ngokukhawuleza ukuba uxubushe ukuba uthathe elinye ipilisi.
Qaphela: Ngokubanzi, ukukhulelwa kwexesha elingxamisekileyo kungasetyenziswa ukuya kwiintsuku ezingama-5 emva kwesondo esingakhuselekanga. Ngoko kusenokuba luncedo ukuthatha iPlani B Isinye Isinyathelo ukuya kwiiyure ezingama-120 emva kwesondo esingakhuselekanga.
Imiphumela
Xa isetyenziswe njengoko kulandiswe, iSicwangciso B Isinye Isinyathelo sikhuselekileyo kuninzi lwabasetyhini. Iziphumo eziqhelekileyo eziqhelekileyo kwilingo leklinikhi kubasetyhini abafumana iSicwangciso B Isinyathelo esinye Isinyathelo sibandakanya:
- Ukuphuma kwexesha lokunyuka komzimba (30.9%)
- Isihlunu (13.7%)
- Ubuhlungu besisu esiswini (13.3%)
- Ukukhathala (13.3%)
- Intloko (10.3%)
- Utywala (9.6%)
- Ubumnini besisu (8.2%)
- Ukukhawuleza kwexesha (ngaphezulu kweentsuku ezi-7) (4.5%)
Emva kokuthatha Isicwangciso B Isinyathelo esinye, unokufumana utshintsho kwixesha lakho. Kwezinye iimeko, ixesha lakho elizayo linokuba lunzima okanye lilula, okanye ngaphambili okanye kamva.
- Kubalulekile ukudibana nogqirha ukuba ixesha lakho elihlelwe lixesha elingaphezu kweyure evekini, njengoko oku kubonisa ukuba ukukhulelwa kwenzeka.
Ukuba ufumana iintlungu ezinzima zesisu emva kweiveki ezi-3 ukuya kwezi-5 emva kokuthatha Isicwangciso B Isinyathelo esinye, kunokukhokelela ukuba unokukhulelwa kwe-ectopic, ngoko kufuneka ufune unyango olusisiseko-ngokubanzi, i-akhawunti yokukhulelwa kwe-ectopic malunga ne-2% konke ukukhulelwa okubiweyo. Sekunjalo, ukuya kwi-10% yokukhulelwa echazwe kwizifundo zokusetyenziswa ngokuqhelekileyo kwezicwangciso zokukhulelwa kwe- progestin kuphela zi-ectopic.
Impumelelo
Cwangciso B Inye-nyathelo iyasebenza ngokukhawuleza ukuba iqalile. Xa kuthatyathwa njengalathwayo (kwiiyure ezingama-72 zesini esingakhuselekanga okanye ukuhluleka kokukhulelwa), isicwangciso B Isinyathelo esinye Isithuba esiphezulu se-89% ekunciphiseni ithuba lokukhulelwa. Abafazi abali-7 kwaba-8 abaza kuba bekhulelwe abayi kukhulelwa emva kokuthatha Isicwangciso B Isinyathelo esinye.
Cwangcisa B Isinyathelo esinye-nanjalo asiyi kuqhubeka nokukhusela ukukhulelwa ngexesha lomjikelo womfazi. Umenzi uthi "ukubuyela ngokukhawuleza kokuzala kubonakala kulandele unyango ngeCwangciso B enye inyathelo yokukhulelwa ngokukhawuleza," ukwenzela ukuba iinkqubo ezongezelelweyo zokukhulelwa kufuneka ziqhutywe okanye ziqaliswe ngokukhawuleza emva kokusetyenziswa kweSicwangciso B esitsha ukuqinisekisa ukukhusela okuqhubekayo. khulelwa.
Iindleko
Iindleko zepakethi enye yeCwangciso B Elinye INyathelo liyakwazi ukuhlahlela ukusuka kwi-$ 35 ukuya kwii-65 zama-65 ... ngeendleko eziqhelekileyo zibe nge-$ 45.
Khuselo lwe STD:
Isicwangciso B Isinye Isinyathelo asiboneli ukhuselo kwizifo ezithathelwana ngesondo okanye i-HIV.
Imithombo:
FDA. (Epreli 30, 2013). I-FDA ivuma iSicwangciso B Isinyathelo esisinye sokunyanga okukhawulezayo ngaphandle kokufumana imithi yabasetyhini abaneminyaka eli-15 ubudala nangaphezulu. Fi kelele 5/1/13
Munro ML, Dulin AC, Kuzma E. "Imbali, umgaqo-nkqubo kunye noobuhlengikazi impembelelo yeCwangciso B® yokukhusela ngokukhawuleza." Abahlengikazi beMpilo yabasetyhini . 2015; 19 (2): 142-153. i-doi: 10.1111 / 1751-486x12186.